53966 Federal Register / Vol. 71, No.

177 / Wednesday, September 13, 2006 / Rules and Regulations

the right to make a unilateral filing with marginale susceptible to Inter-

FERC to modify this Agreement under
any applicable provision of the Federal
Power Act and FERC’s rules and
regulations; provided that each party
shall have the right to protest any such
filing by the other Party and to
participate fully in any proceeding
before FERC in which such
modifications may be considered.
Nothing in this Agreement shall limit
the rights of the parties or of FERC
under sections 205 or 206 of the Federal
Power Act and FERC’s rules and
regulations, except to the extent that the
parties otherwise agree as provided
herein.’’
Magalie R. Salas,
Secretary.
[FR Doc. E6–15126 Filed 9–12–06; 8:45 am]
BILLING CODE 6717–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Part 558
New Animal Drugs for Use in Animal
Feeds; Chlortetracycline
AGENCY: Food and Drug Administration,
HHS.
Final rule, technical
ACTION:
amendment.
SUMMARY: The Food and Drug
Administration (FDA) is amending the
animal drug regulations to reflect
approval of a supplemental new animal
drug application (NADA) filed by
Alpharma Inc. The supplemental NADA
provides for use of an approved Type A
medicated article containing
chlortetracycline to formulate a free-
choice loose mineral Type C medicated
Per-
chlortetracycline. The supplemental Ingredient cent national
NADA is approved as of July 28, 2006, Feed No.
and the regulations are amended in 21
Cottonseed Meal 10.00 5–01–
CFR 558.128 to reflect the approval. The 625
basis of approval is discussed in the Trace Mineral/Vitamin 3.80
freedom of information summary. Premix1
In accordance with the freedom of Calcium Carbonate 3.50 6–01–
information provisions of 21 CFR part 069
20 and 21 CFR 514.11(e)(2)(ii), a Dried Cane Molasses 3.00 4–04–
summary of safety and effectiveness 695
data and information submitted to Potassium Chloride 2.00 6–03–
support approval of this application 755
may be seen in the Division of Dockets Mineral Oil 2.00 8–03–
123
Management (HFA–305), Food and Drug Iron Oxide 0.50 6–02–
Administration, 5630 Fishers Lane, rm. 431
1061, Rockville, MD 20852, between 9 Chlortetracycline Type A 3.33
a.m. and 4 p.m., Monday through medicated article (90
Friday. gram/lb)
The agency has determined under 21 1Content of vitamin and trace mineral pre-
CFR 25.33(a)(1) that this action is of a mixes may be varied. However, they should
type that does not individually or be comparable to those used for other free-
cumulatively have a significant effect on choice feeds. Formulation modifications re-
the human environment. Therefore, quire FDA approval prior to marketing. Sele-
nium must comply with 21 CFR 573.920.
neither an environmental assessment Ethylenediamine dihydroiodide (EDDI) should
nor an environmental impact statement comply with FDA Compliance Policy Guides
is required. Sec. 651.100 (CPG 7125.18).
This rule does not meet the definition (ii) Amount. 6,000 grams per ton.
of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because (iii) Indications for use. Beef and
it is a rule of ‘‘particular applicability.’’ nonlactating dairy cattle: As an aid in
Therefore, it is not subject to the the control of active infection of
congressional review requirements in 5
anaplasmosis caused by Anaplasma
U.S.C. 801–808. marginale susceptible to
List of Subjects in 21 CFR Part 558 chlortetracycline.
(iv) Limitations. Feed continuously on
Animal drugs, Animal feeds.
a free-choice basis at a rate of 0.5 to 2.0
■ Therefore, under the Federal Food,
mg chlortetracycline per head per day.
Drug, and Cosmetic Act and under
(v) Sponsor. See No. 046573 in
authority delegated to the Commissioner
§ 510.600(c) of this chapter.
of Food and Drugs and redelegated to
the Center for Veterinary Medicine, 21 * * * * *
CFR part 558 is amended as follows: Dated: August 30, 2006.
Steven D. Vaughn,
PART 558—NEW ANIMAL DRUGS FOR Director, Office of New Animal Drug
USE IN ANIMAL FEEDS Evaluation, Center for Veterinary Medicine.
[FR Doc. E6–15103 Filed 9–12–06; 8:45 am]
■ 1. The authority citation for 21 CFR
part 558 continues to read as follows: BILLING CODE 4160–01–S

feed for beef and nonlactating dairy Authority: 21 U.S.C. 360b, 371.
cattle. ■ 2. In § 558.128, redesignate paragraph DEPARTMENT OF THE TREASURY
DATES: This rule is effective September (e)(6) as paragraph (e)(7); and add new
13, 2006. paragraph (e)(6) to read as follows: Internal Revenue Service
FOR FURTHER INFORMATION CONTACT: Eric § 558.128 Chlortetracycline.
S. Dubbin, Center for Veterinary 26 CFR Part 54
Medicine (HFV–126), Food and Drug * * * * *
(e) * * * [TD 9277]
Administration, 7500 Standish Pl., (6) It is used as a free-choice, loose
Rockville, MD 20855, 301–827–0232, e- RIN 1545–BE30
mineral Type C feed as follows:
mail: eric.dubbin@fda.hhs.gov. (i) Specifications. Employer Comparable Contributions to
SUPPLEMENTARY INFORMATION: Alpharma
Health Savings Accounts Under
Inc., One Executive Dr., Fort Lee, NJ Inter- Section 4980G; Correction
Per-
07024, filed NADA 48–761 for use of Ingredient cent national
AUREOMYCIN 90 Granular Feed No. AGENCY: Internal Revenue Service (IRS),
(chlortetracycline) Type A medicated Treasury.
rmajette on PROD1PC67 with RULES1

Dicalcium Phosphate 46.20 6–26–

article to formulate a free-choice loose 335 ACTION: Correcting amendment.
mineral Type C medicated feed for beef Sodium Chloride (Salt) 15.00 6–04–
and nonlactating dairy cattle as an aid 152 SUMMARY: This document contains a
in the control of active infection of Magnesium Oxide 10.67 6–02– correction to final regulations (TD 9277)
anaplasmosis caused by Anaplasma 756 that were published in the Federal

VerDate Aug<31>2005 16:23 Sep 12, 2006 Jkt 208001 PO 00000 Frm 00004 Fmt 4700 Sfmt 4700 E:\FR\FM\13SER1.SGM 13SER1